A bibliometric analysis of CD38-targeting antibody therapy in multiple myeloma from 1985 to 2021

BACKGROUND: CD38 is a transmembrane glycoprotein that is relatively highly expressed on multiple myeloma (MM) cells, and CD38-targeting antibodies use pleiotropic mechanisms to kill MM cells. Immunotherapy, with an increased quality of response and acceptable toxicity, shows tremendous potential for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Hanyi, Zhang, Xiaoyuan, Gang, Dongxu, He, Xiaoyu, Jiang, Songfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091016/
https://www.ncbi.nlm.nih.gov/pubmed/35571665
http://dx.doi.org/10.21037/tcr-21-1962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091016/
https://www.ncbi.nlm.nih.gov/pubmed/35571665
http://dx.doi.org/10.21037/tcr-21-1962

Ejemplares similares